T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
American Express
AXP
$230B
| $1.16B | 0.25% |
12,497,317
-4,280,011
| -26% | -$384M |
|
102
Applied Materials
AMAT
$417B
| $1.16B | 0.25% |
46,529,266
-1,729,583
| -4% | -$39.1M |
|
103
Verizon
VZ
$196B
| $1.16B | 0.25% |
24,784,624
-1,595,876
| -6% | -$78.1M |
|
|
TWX
104
DELISTED
Time Warner Inc
TWX
| $1.16B | 0.25% |
13,566,442
+275,235
| +2% | +$21.9M |
|
105
Kohl's
KSS
$2.1B
| $1.14B | 0.24% |
18,756,305
-1,115,930
| -6% | -$64.5M |
|
106
International Paper
IP
$22.1B
| $1.12B | 0.24% |
22,098,524
-5,792,177
| -21% | -$284M |
|
107
Exelon
EXC
$46.2B
| $1.11B | 0.24% |
42,017,822
+5,416,837
| +15% | +$139M |
|
108
Procter & Gamble
PG
$338B
| $1.11B | 0.24% |
12,196,139
-4,426,358
| -27% | -$389M |
|
|
COV
109
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $1.06B | 0.23% |
10,397,194
-274,384
| -3% | -$26.3M |
|
110
Entergy
ETR
$49.7B
| $1.06B | 0.23% |
24,302,400
+295,710
| +1% | +$12.3M |
|
|
HES
111
DELISTED
Hess
HES
| $1.05B | 0.22% |
14,190,260
+1,554,699
| +12% | +$123M |
|
|
TYC
112
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $1.04B | 0.22% |
22,550,113
+1,439,947
| +7% | +$64.1M |
|
113
Celanese
CE
$4.92B
| $1.03B | 0.22% |
17,247,399
-644,825
| -4% | -$37.7M |
|
114
AbbVie
ABBV
$442B
| $1.03B | 0.22% |
15,792,791
-281,604
| -2% | -$17.8M |
|
115
Northern Trust
NTRS
$34.4B
| $1.03B | 0.22% |
15,322,381
-1,100,634
| -7% | -$73.2M |
|
116
3M
MMM
$94.4B
| $1.02B | 0.22% |
7,460,235
-1,396,458
| -16% | -$179M |
|
|
117
Ecolab
ECL
$79.8B
| $1.01B | 0.21% |
9,616,236
-10,699,392
| -53% | -$1.17B |
|
118
Comcast
CMCSA
$91B
| $1B | 0.21% |
34,550,628
+5,737,722
| +20% | +$157M |
|
119
ServiceNow
NOW
$132B
| $990M | 0.21% |
72,943,960
-1,125,185
| -2% | -$14.3M |
|
120
Illinois Tool Works
ITW
$83.5B
| $978M | 0.21% |
10,331,132
+23,072
| +0.2% | +$2.1M |
|
|
RDS.A
121
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $975M | 0.21% |
15,599,333
-4,117,838
| -21% | -$266M |
|
122
Alkermes
ALKS
$8.26B
| $948M | 0.2% |
16,184,068
-16,752
| -0.1% | -$853K |
|
|
CFN
123
DELISTED
CAREFUSION CORPORATION
CFN
| $946M | 0.2% |
15,947,123
-2,288,483
| -13% | -$131M |
|
124
Simon Property Group
SPG
$71.2B
| $943M | 0.2% |
5,177,444
-181,182
| -3% | -$32.1M |
|
125
NiSource
NI
$20.1B
| $933M | 0.2% |
55,969,452
-9,341,463
| -14% | -$152M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.